Founded in 2011 as a part of the California Institute of Quantitative Biosciences (qb3) and the Johnson and Johnson Innovation Center (Jansen Labs), Agarionan Inc specializes in utilizing microfluidics technology to detect and diagnose epithelial cancers at an early stage. The company was acquired in 2014.